News

Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans

Policy Updates Impact Nationwide Commercial Plans for 16.8 Million Covered LivesMALVERN, Pa., July 19, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc.…

1 year ago

Abeona Therapeutics Joins Rare Disease Company Coalition

CLEVELAND, July 19, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that it has joined the Rare…

1 year ago

Zymeworks To Host Second Quarter 2023 Results Conference Call

VANCOUVER, British Columbia, July 19, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional…

1 year ago

QM Racing Inc., a 100% owned subsidiary of Quad M Solutions, Inc., signs definitive agreement to purchase 100 percent of REV Technologies.

Garland, TX, July 19, 2023 (GLOBE NEWSWIRE) -- QM Racing, Inc. (QM Racing), a subsidiary of Quad M Solutions, Inc., (OTC:…

1 year ago

Carmot Therapeutics Appoints Charles W. Newton to Board of Directors

Biotechnology industry executive and former healthcare investment banker with proven track record of advising management teams on corporate and financial…

1 year ago

Journey Medical Corporation to Announce Second Quarter 2023 Financial Results the Week of August 7, 2023

Company to host conference call to discuss financial results and provide a corporate update the week of August 7, 2023SCOTTSDALE,…

1 year ago

Inozyme Pharma to Provide ENPP1 Deficiency Program Update on July 26, 2023

– Conference call and webcast to be held on July 26, 2023, at 8am ET – BOSTON, July 19, 2023…

1 year ago

Tenax Therapeutics Issued U.S. Patent for Oral Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

New U.S. patent provides intellectual property (IP) protection until December 2040, and may qualify for term extension beyond 2040There are…

1 year ago

First Wave BioPharma, Inc. Announces Pricing of $2.1 Million Public Offering

BOCA RATON, Fla., July 19, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”),…

1 year ago

Akari Therapeutics Appoints Experienced Life Sciences Executive Wendy DiCicco as Interim Chief Financial Officer

NEW YORK and LONDON, July 19, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing…

1 year ago